Skip to content
Life sciences consumables, equipment and services, delivered across Saudi Arabia.
Anti-MCM6 Antibody
  • Anti-MCM6 Antibody
Antibodies.com

Anti-MCM6 Antibody

Price on request

SKUPriceQuantity
A35506-50

Price on request

Description

This description has not been verified against the manufacturer's datasheet. Check the datasheet before you order, or ask us to confirm a specification. Ask us to confirm

Manufactured by Antibodies.com, this affinity-purified Rabbit polyclonal reagent targets the DNA replication licensing factor MCM6 (also known as p105MCM), a ~91 kDa helicase component essential for eukaryotic genome replication. The antibody is raised against a recombinant full-length human MCM6 immunogen and is supplied at 1 mg/ml in PBS with 0.1% sodium azide and 50% glycerol as a stabiliser, with reported purity exceeding 95% by SDS-PAGE. It is provided unconjugated in a 50 µl volume, making it suitable for routine immunodetection workflows in research laboratories. Validated applications include Western Blotting (WB), Immunohistochemistry (IHC) and Immunofluorescence (IF), and the polyclonal antibody has been confirmed to detect endogenous MCM6 protein levels in Human, Mouse and Rat samples, supporting cross-species studies in cell biology and oncology research. As a polyclonal host Rabbit IgG preparation, the reagent offers broad epitope coverage for the MCM6 target. For optimal preservation of activity, the product should be stored according to the manufacturer's recommendations, typically at -20 °C in small aliquots to avoid repeated freeze-thaw cycles, given the glycerol-containing buffer. This reagent is intended strictly for research use only and is not approved for diagnostic or therapeutic applications, a standard caveat documented across the Antibodies.com primary antibody portfolio. The combination of cross-species reactivity, multi-application validation, and a well-characterised full-length immunogen makes this MCM6 antibody a practical choice for investigators studying replication licensing, proliferation markers and DNA damage response pathways.